Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients

Leukemia Research

Volumn 31, Issue 9, 2007, Pages 1191-1197

  Niitsu, Nozomi ^a,b   Okamoto, Masataka ^b   Nakamura, Naoya ^b   Nakamine, Hirokazu ^b   Aoki, Sadao ^b   Hirano, Masami ^b   Miura, Ikuo ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Adult Lymphoma Treatment Study Group: ALTSG   (Japan)

Author keywords

3q27 translocation; Chromosome; Diffuse large B cell lymphoma; Follicular lymphoma; Prognostic factor

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROTEIN BCL 6; VINCRISTINE; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR LYMPHOMA; GENE TRANSLOCATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; CHROMOSOME 18; CHROMOSOME 3; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETICS; KARYOTYPING; LARGE CELL LYMPHOMA; METABOLISM; MIDDLE AGED; SURVIVAL RATE;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 34249874920     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.09.008     Document Type: Article

References (21)

1. Ye B.H., Lista F., Lo Coco F., Knowles D.M., Offit K., Chaganti R.S., et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262 (1993) 747-750
2. Kerckaert J.P., Deweindt C., Tilly H., Quief S., Lecocq G., and Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5 (1993) 66-70
3. Phan R.T., and Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432 (2004) 635-639
4. Ye B.H., Chaganti S., Chang C.-C., Niu H., Corradini P., Chaganti R.S., et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14 (1995) 6209-6217
5. Migliazza A., Martinotti S., Chen W., Fusco C., Ye B.H., Knowles D.M., et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92 (1995) 12520-12524
6. Shen H.M., Peters A., Baron B., Zhu X., and Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280 (1998) 1750-1752
7. Bastard C., Tilly H., Lenormand B., Bigorgne C., Boulet D., Kunlin A., et al. Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood 79 (1992) 2527-2531
8. Akasaka H., Akasaka T., Kurata M., Ueda C., Shimizu A., Uchiyama T., et al. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 60 (2000) 2335-2341
9. Offit K., Lo Coco F., Louie D.C., Parsa N.Z., Leung D., Portlock C., et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331 (1994) 74-80
10. Muramatsu M., Akasaka T., Kadowaki N., Ohno H., Fukuhara S., and Okuma M. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leukemia 11 (1997) 318-320
11. Jerkeman M., Aman P., Cavallin-Stahl E., Torlakovic E., Akerman M., Mitelman F., et al. Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma-A Nordic Lymphoma Group Study. Int J Oncol 20 (2002) 161-165
12. Bastard C., Deweindt C., Kerckaert J.P., Lenormand B., Rossi A., Pezzella F., et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83 (1994) 2423-2427
13. Kramer M.H., Hermans J., Wijburg E., Philippo K., Geelen E., van Krieken J.H., et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 92 (1998) 3152-13152
14. Pescarmona E., De Sanctis V., Pistilli A., Pacchiarotti A., Martelli M., Guglielmi C., et al. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J Pathol 183 (1997) 281-286
15. Niitsu N., Okamoto M., Aoki S., Kuraishi Y., Okumura H., and Hirano M. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma. Ann Haematol 85 (2006) 374-380
16. Hashimoto K., Miura I., Chyubachi A., Saito M., and Miura A.B. Correlations of chromosome abnormalities with histologic and immunologic characteristics in 49 patients from Akita, Japan with non-Hodgkin lymphoma. Cancer Genet Cytogenet 81 (1995) 56-65
17. Mitelman F. An international system for human cytogenetic nomenclature (1995), ISCN, S. Karger, Basel
18. Barrans S.L., O'Connor S.J., Evans P.A., Davies F.E., Owen R.G., Haynes A.P., et al. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 117 (2002) 322-332
19. Katsumata N., Matsuno Y., Nakayama H., Takenaka T., Kobayashi Y., Takeyama K., et al. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan. Jpn J Clin Oncol 26 (1996) 445-454
20. Martinka M., Comeau T., Foyle A., Anderson D., and Greer W. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clin Invest Med 20 (1997) 364-370
21. Lopez-Guillermo A., Cabanillas F., McDonnell T.I., McLaughlin P., Smith T., Pugh W., et al. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 93 (1999) 3081-3087